Structure

Physi-Chem Properties

Molecular Weight:  500.35
Volume:  543.911
LogP:  4.699
LogD:  4.202
LogS:  -5.143
# Rotatable Bonds:  7
TPSA:  80.67
# H-Bond Aceptor:  5
# H-Bond Donor:  1
# Rings:  4
# Heavy Atoms:  5

MedChem Properties

QED Drug-Likeness Score:  0.448
Synthetic Accessibility Score:  5.005
Fsp3:  0.839
Lipinski Rule-of-5:  Accepted
Pfizer Rule:  Accepted
GSK Rule:  Rejected
BMS Rule:  0
Golden Triangle Rule:  Rejected
Chelating Alert:  0
PAINS Alert:  0

ADMET Properties (ADMETlab2.0)

ADMET: Absorption

Caco-2 Permeability:  -5.063
MDCK Permeability:  2.087960092467256e-05
Pgp-inhibitor:  0.994
Pgp-substrate:  0.0
Human Intestinal Absorption (HIA):  0.003
20% Bioavailability (F20%):  0.831
30% Bioavailability (F30%):  0.98

ADMET: Distribution

Blood-Brain-Barrier Penetration (BBB):  0.307
Plasma Protein Binding (PPB):  86.85115051269531%
Volume Distribution (VD):  0.674
Pgp-substrate:  4.289594650268555%

ADMET: Metabolism

CYP1A2-inhibitor:  0.015
CYP1A2-substrate:  0.512
CYP2C19-inhibitor:  0.199
CYP2C19-substrate:  0.909
CYP2C9-inhibitor:  0.333
CYP2C9-substrate:  0.065
CYP2D6-inhibitor:  0.007
CYP2D6-substrate:  0.039
CYP3A4-inhibitor:  0.92
CYP3A4-substrate:  0.898

ADMET: Excretion

Clearance (CL):  5.559
Half-life (T1/2):  0.067

ADMET: Toxicity

hERG Blockers:  0.045
Human Hepatotoxicity (H-HT):  0.197
Drug-inuced Liver Injury (DILI):  0.11
AMES Toxicity:  0.018
Rat Oral Acute Toxicity:  0.311
Maximum Recommended Daily Dose:  0.909
Skin Sensitization:  0.166
Carcinogencity:  0.021
Eye Corrosion:  0.003
Eye Irritation:  0.018
Respiratory Toxicity:  0.977

Download Data

Data Type Select
General Info & Identifiers & Properties  
Structure MOL file  
Source Organisms  
Biological Activities  
Similar NPs/Drugs  

  Natural Product: NPC253826

Natural Product ID:  NPC253826
Common Name*:   Methyl (E,4R,6R)-4-Hydroxy-6-[(3R,5R,9R,10R,13S,17S)-3-Hydroxy-4,4,10,13,17-Pentamethyl-15-Oxo-1,2,3,5,6,7,9,11,12,16-Decahydrocyclopenta[A]Phenanthren-17-Yl]-2-Methylhept-2-Enoate
IUPAC Name:   methyl (E,4R,6R)-4-hydroxy-6-[(3R,5R,9R,10R,13S,17S)-3-hydroxy-4,4,10,13,17-pentamethyl-15-oxo-1,2,3,5,6,7,9,11,12,16-decahydrocyclopenta[a]phenanthren-17-yl]-2-methylhept-2-enoate
Synonyms:  
Standard InCHIKey:  SBOYORXZEZYALE-YMHVJQCZSA-N
Standard InCHI:  InChI=1S/C31H48O5/c1-18(27(35)36-8)15-20(32)16-19(2)31(7)17-23(33)26-21-9-10-24-28(3,4)25(34)12-13-29(24,5)22(21)11-14-30(26,31)6/h15,19-20,22,24-25,32,34H,9-14,16-17H2,1-8H3/b18-15+/t19-,20+,22+,24+,25-,29-,30-,31+/m1/s1
SMILES:  COC(=O)/C(=C/[C@@H](C[C@H]([C@]1(C)CC(=O)C2=C3[C@H](CC[C@@]12C)[C@@]1(C)CC[C@H](C([C@@H]1CC3)(C)C)O)C)O)/C
Synthetic Gene Cluster:   n.a.
ChEMBL Identifier:   CHEMBL487488
PubChem CID:   44575715
Chemical Classification**:  
  • CHEMONTID:0000000 [Organic compounds]
    • [CHEMONTID:0000012] Lipids and lipid-like molecules
      • [CHEMONTID:0000258] Steroids and steroid derivatives
        • [CHEMONTID:0001445] Bile acids, alcohols and derivatives
          • [CHEMONTID:0002194] Hydroxy bile acids, alcohols and derivatives
            • [CHEMONTID:0000516] Dihydroxy bile acids, alcohols and derivatives

*Note: the InCHIKey will be temporarily assigned as the "Common Name" if no IUPAC name or alternative short name is available.
**Note: the Chemical Classification was calculated by NPClassifier Version 1.5. Reference: PMID:34662515.

  Species Source

Organism ID Organism Name Taxonomy Level Family SuperKingdom Isolation Part Collection Location Collection Time Reference
NPO25515 Garcinia speciosa Species Clusiaceae Eukaryota barks n.a. n.a. PMID[15620248]
NPO25515 Garcinia speciosa Species Clusiaceae Eukaryota n.a. n.a. n.a. Database[HerDing]
NPO25515 Garcinia speciosa Species Clusiaceae Eukaryota n.a. n.a. n.a. Database[TCMID]
NPO25515 Garcinia speciosa Species Clusiaceae Eukaryota n.a. n.a. n.a. Database[UNPD]

☑ Note for Reference:
In addition to directly collecting NP source organism data from primary literature (where reference will provided as NCBI PMID or DOI links), NPASS also integrated them from below databases:
UNPD: Universal Natural Products Database [PMID: 23638153].
StreptomeDB: a database of streptomycetes natural products [PMID: 33051671].
TM-MC: a database of medicinal materials and chemical compounds in Northeast Asian traditional medicine [PMID: 26156871].
TCM@Taiwan: a Traditional Chinese Medicine database [PMID: 21253603].
TCMID: a Traditional Chinese Medicine database [PMID: 29106634].
TCMSP: The traditional Chinese medicine systems pharmacology database and analysis platform [PMID: 24735618].
HerDing: a herb recommendation system to treat diseases using genes and chemicals [PMID: 26980517].
MetaboLights: a metabolomics database [PMID: 27010336].
FooDB: a database of constituents, chemistry and biology of food species [www.foodb.ca].

  NP Quantity Composition/Concentration

Organism ID NP ID Organism Material Preparation Organism Part NP Quantity (Standard) NP Quantity (Minimum) NP Quantity (Maximum) Quantity Unit Reference

☑ Note for Reference:
In addition to directly collecting NP quantitative data from primary literature (where reference will provided as NCBI PMID or DOI links), NPASS also integrated NP quantitative records for specific NP domains (e.g., NPS from foods or herbs) from domain-specific databases. These databases include:
DUKE: Dr. Duke's Phytochemical and Ethnobotanical Databases.
PHENOL EXPLORER: is the first comprehensive database on polyphenol content in foods [PMID: 24103452], its homepage can be accessed at here.
FooDB: a database of constituents, chemistry and biology of food species [www.foodb.ca].

  Biological Activity

Target ID Target Type Target Name Target Organism Activity Type Activity Relation Value Unit Reference
NPT83 Cell Line MCF7 Homo sapiens GI50 = 26000.0 nM PMID[565118]
NPT397 Cell Line NCI-H460 Homo sapiens GI50 = 42700.0 nM PMID[565118]
NPT395 Cell Line SF-268 Homo sapiens GI50 = 44700.0 nM PMID[565118]
NPT83 Cell Line MCF7 Homo sapiens Activity = 26.36 % PMID[565118]

☑ Note for Activity Records:
☉ The quantitative biological activities were primarily integrated from ChEMBL (Version-30) database and were also directly collected from PubMed literature. PubMed PMID was provided as the reference link for each activity record.

  Chemically structural similarity: I. Similar Active Natural Products in NPASS

Top-200 similar NPs were calculated against the active-NP-set (includes 4,3285 NPs with experimentally-derived bioactivity available in NPASS)

Similarity level is defined by Tanimoto coefficient (Tc) between two molecules. Tc lies between [0, 1] where '1' indicates the highest similarity. What is Tanimoto coefficient

●  The left chart: Distribution of similarity level between NPC253826 and all remaining natural products in the NPASS database.
●  The right table: Most similar natural products (Tc>=0.56 or Top200).

Similarity Score Similarity Level Natural Product ID
0.9255 High Similarity NPC57079
0.9255 High Similarity NPC108368
0.9043 High Similarity NPC301534
0.9043 High Similarity NPC250757
0.8958 High Similarity NPC201406
0.8925 High Similarity NPC139692
0.8901 High Similarity NPC104560
0.8889 High Similarity NPC266570
0.8878 High Similarity NPC112009
0.8854 High Similarity NPC478056
0.8842 High Similarity NPC242848
0.8842 High Similarity NPC472941
0.8842 High Similarity NPC456
0.8842 High Similarity NPC134072
0.8842 High Similarity NPC234993
0.8817 High Similarity NPC473998
0.8817 High Similarity NPC472975
0.8804 High Similarity NPC472240
0.8804 High Similarity NPC473999
0.8804 High Similarity NPC262858
0.8804 High Similarity NPC309603
0.8778 High Similarity NPC470574
0.8776 High Similarity NPC155332
0.8776 High Similarity NPC136289
0.8776 High Similarity NPC293753
0.8776 High Similarity NPC114540
0.8776 High Similarity NPC32577
0.8763 High Similarity NPC476274
0.8763 High Similarity NPC251680
0.8763 High Similarity NPC266955
0.875 High Similarity NPC108078
0.875 High Similarity NPC320306
0.875 High Similarity NPC474343
0.8737 High Similarity NPC476174
0.8723 High Similarity NPC472871
0.8723 High Similarity NPC38232
0.871 High Similarity NPC48010
0.871 High Similarity NPC477147
0.871 High Similarity NPC477149
0.87 High Similarity NPC189863
0.8687 High Similarity NPC180204
0.8687 High Similarity NPC476237
0.8681 High Similarity NPC322159
0.8673 High Similarity NPC282524
0.8673 High Similarity NPC476240
0.8673 High Similarity NPC224720
0.8673 High Similarity NPC81530
0.8673 High Similarity NPC115899
0.8673 High Similarity NPC476223
0.8654 High Similarity NPC122056
0.8646 High Similarity NPC190713
0.8646 High Similarity NPC328371
0.8646 High Similarity NPC202833
0.8646 High Similarity NPC7124
0.8641 High Similarity NPC474315
0.8632 High Similarity NPC91010
0.8632 High Similarity NPC8993
0.8632 High Similarity NPC299100
0.8632 High Similarity NPC469406
0.8617 High Similarity NPC472978
0.8617 High Similarity NPC475806
0.8614 High Similarity NPC475294
0.8602 High Similarity NPC474704
0.8602 High Similarity NPC146554
0.8602 High Similarity NPC475921
0.8602 High Similarity NPC5509
0.8602 High Similarity NPC214387
0.8602 High Similarity NPC472973
0.86 High Similarity NPC472868
0.8587 High Similarity NPC474684
0.8587 High Similarity NPC142361
0.8586 High Similarity NPC234892
0.8571 High Similarity NPC476299
0.8571 High Similarity NPC327431
0.8571 High Similarity NPC147912
0.8571 High Similarity NPC474012
0.8571 High Similarity NPC287833
0.8571 High Similarity NPC67259
0.8571 High Similarity NPC117685
0.8558 High Similarity NPC264634
0.8542 High Similarity NPC180950
0.8542 High Similarity NPC174948
0.8542 High Similarity NPC469995
0.8542 High Similarity NPC470016
0.8542 High Similarity NPC317586
0.8542 High Similarity NPC271195
0.8542 High Similarity NPC173875
0.8542 High Similarity NPC318282
0.8542 High Similarity NPC183012
0.8526 High Similarity NPC170220
0.8526 High Similarity NPC107674
0.8526 High Similarity NPC141497
0.8526 High Similarity NPC214756
0.8526 High Similarity NPC109305
0.8526 High Similarity NPC214697
0.8526 High Similarity NPC69454
0.8526 High Similarity NPC476304
0.8526 High Similarity NPC272075
0.8526 High Similarity NPC295643
0.8511 High Similarity NPC476437
0.8511 High Similarity NPC469400
0.8511 High Similarity NPC476369
0.8511 High Similarity NPC51486
0.8511 High Similarity NPC471896
0.85 High Similarity NPC476889
0.85 High Similarity NPC329345
0.85 High Similarity NPC475526
0.85 High Similarity NPC478057
0.85 High Similarity NPC473283
0.85 High Similarity NPC95899
0.85 High Similarity NPC72151
0.8495 Intermediate Similarity NPC48107
0.8485 Intermediate Similarity NPC472924
0.8485 Intermediate Similarity NPC303559
0.8485 Intermediate Similarity NPC168319
0.8485 Intermediate Similarity NPC471412
0.8485 Intermediate Similarity NPC194028
0.8478 Intermediate Similarity NPC472985
0.8478 Intermediate Similarity NPC472986
0.8478 Intermediate Similarity NPC73038
0.8469 Intermediate Similarity NPC235464
0.8469 Intermediate Similarity NPC166745
0.8469 Intermediate Similarity NPC218107
0.8469 Intermediate Similarity NPC98868
0.8469 Intermediate Similarity NPC316598
0.8469 Intermediate Similarity NPC197386
0.8469 Intermediate Similarity NPC103051
0.8469 Intermediate Similarity NPC114274
0.8454 Intermediate Similarity NPC471153
0.8454 Intermediate Similarity NPC249954
0.8454 Intermediate Similarity NPC29152
0.8438 Intermediate Similarity NPC184870
0.8438 Intermediate Similarity NPC57117
0.8438 Intermediate Similarity NPC279410
0.8438 Intermediate Similarity NPC472976
0.8438 Intermediate Similarity NPC166906
0.8438 Intermediate Similarity NPC119562
0.8438 Intermediate Similarity NPC474690
0.8438 Intermediate Similarity NPC476415
0.8438 Intermediate Similarity NPC472977
0.8438 Intermediate Similarity NPC476186
0.8431 Intermediate Similarity NPC329048
0.8431 Intermediate Similarity NPC472925
0.8431 Intermediate Similarity NPC91034
0.8431 Intermediate Similarity NPC330011
0.8421 Intermediate Similarity NPC233455
0.8421 Intermediate Similarity NPC474018
0.8421 Intermediate Similarity NPC86266
0.8421 Intermediate Similarity NPC145067
0.8421 Intermediate Similarity NPC110923
0.8421 Intermediate Similarity NPC72845
0.8421 Intermediate Similarity NPC297265
0.8421 Intermediate Similarity NPC212948
0.8421 Intermediate Similarity NPC110657
0.8421 Intermediate Similarity NPC74296
0.8421 Intermediate Similarity NPC473986
0.8421 Intermediate Similarity NPC472814
0.8421 Intermediate Similarity NPC65120
0.8421 Intermediate Similarity NPC4036
0.8421 Intermediate Similarity NPC177037
0.8421 Intermediate Similarity NPC272746
0.8421 Intermediate Similarity NPC189520
0.8421 Intermediate Similarity NPC63748
0.8421 Intermediate Similarity NPC233116
0.8421 Intermediate Similarity NPC158030
0.8421 Intermediate Similarity NPC212301
0.8416 Intermediate Similarity NPC118911
0.8411 Intermediate Similarity NPC20302
0.8411 Intermediate Similarity NPC140055
0.8411 Intermediate Similarity NPC167606
0.8411 Intermediate Similarity NPC470492
0.8411 Intermediate Similarity NPC286528
0.8404 Intermediate Similarity NPC174342
0.8404 Intermediate Similarity NPC474396
0.8404 Intermediate Similarity NPC472983
0.8404 Intermediate Similarity NPC1015
0.8404 Intermediate Similarity NPC31985
0.8404 Intermediate Similarity NPC262043
0.8404 Intermediate Similarity NPC50488
0.84 Intermediate Similarity NPC320447
0.84 Intermediate Similarity NPC119601
0.84 Intermediate Similarity NPC40918
0.84 Intermediate Similarity NPC476890
0.84 Intermediate Similarity NPC308726
0.8387 Intermediate Similarity NPC136948
0.8387 Intermediate Similarity NPC187376
0.8387 Intermediate Similarity NPC475740
0.8387 Intermediate Similarity NPC159046
0.8387 Intermediate Similarity NPC233836
0.8384 Intermediate Similarity NPC470074
0.8384 Intermediate Similarity NPC307954
0.8384 Intermediate Similarity NPC471413
0.8384 Intermediate Similarity NPC51370
0.8384 Intermediate Similarity NPC144660
0.8384 Intermediate Similarity NPC299971
0.8384 Intermediate Similarity NPC471041
0.8384 Intermediate Similarity NPC154072
0.8384 Intermediate Similarity NPC476303
0.8381 Intermediate Similarity NPC147180
0.8381 Intermediate Similarity NPC69291

  Chemically structural similarity: II. Similar Clinical/Approved Drugs

Similarity level is defined by Tanimoto coefficient (Tc) between two molecules.

●  The left chart: Distribution of similarity level between NPC253826 and all drugs/candidates.
●  The right table: Most similar clinical/approved drugs (Tc>=0.56 or Top200).

Similarity Score Similarity Level Drug ID Developmental Stage
0.8763 High Similarity NPD7639 Approved
0.8763 High Similarity NPD7640 Approved
0.866 High Similarity NPD7638 Approved
0.8478 Intermediate Similarity NPD3618 Phase 1
0.8421 Intermediate Similarity NPD6079 Approved
0.8421 Intermediate Similarity NPD7515 Phase 2
0.8411 Intermediate Similarity NPD7115 Discovery
0.8404 Intermediate Similarity NPD5328 Approved
0.8247 Intermediate Similarity NPD7748 Approved
0.8173 Intermediate Similarity NPD6899 Approved
0.8173 Intermediate Similarity NPD6881 Approved
0.8155 Intermediate Similarity NPD6675 Approved
0.8155 Intermediate Similarity NPD7128 Approved
0.8155 Intermediate Similarity NPD6402 Approved
0.8155 Intermediate Similarity NPD5739 Approved
0.8144 Intermediate Similarity NPD6399 Phase 3
0.81 Intermediate Similarity NPD4225 Approved
0.8085 Intermediate Similarity NPD6409 Approved
0.8085 Intermediate Similarity NPD7521 Approved
0.8085 Intermediate Similarity NPD5330 Approved
0.8085 Intermediate Similarity NPD7146 Approved
0.8085 Intermediate Similarity NPD6684 Approved
0.8085 Intermediate Similarity NPD7334 Approved
0.8081 Intermediate Similarity NPD5220 Clinical (unspecified phase)
0.8081 Intermediate Similarity NPD5222 Approved
0.8081 Intermediate Similarity NPD5221 Approved
0.8077 Intermediate Similarity NPD5697 Approved
0.8065 Intermediate Similarity NPD3133 Approved
0.8065 Intermediate Similarity NPD4786 Approved
0.8065 Intermediate Similarity NPD3665 Phase 1
0.8065 Intermediate Similarity NPD3666 Approved
0.8043 Intermediate Similarity NPD3667 Approved
0.8043 Intermediate Similarity NPD4752 Clinical (unspecified phase)
0.8039 Intermediate Similarity NPD5211 Phase 2
0.8039 Intermediate Similarity NPD7632 Discontinued
0.8019 Intermediate Similarity NPD7290 Approved
0.8019 Intermediate Similarity NPD6883 Approved
0.8019 Intermediate Similarity NPD7102 Approved
0.8 Intermediate Similarity NPD5173 Approved
0.8 Intermediate Similarity NPD7902 Approved
0.8 Intermediate Similarity NPD6011 Approved
0.8 Intermediate Similarity NPD6083 Phase 2
0.8 Intermediate Similarity NPD6084 Phase 2
0.8 Intermediate Similarity NPD7320 Approved
0.7959 Intermediate Similarity NPD4202 Approved
0.7944 Intermediate Similarity NPD6869 Approved
0.7944 Intermediate Similarity NPD6649 Approved
0.7944 Intermediate Similarity NPD6847 Approved
0.7944 Intermediate Similarity NPD6650 Approved
0.7944 Intermediate Similarity NPD8130 Phase 1
0.7944 Intermediate Similarity NPD6617 Approved
0.7938 Intermediate Similarity NPD5785 Approved
0.7925 Intermediate Similarity NPD6372 Approved
0.7925 Intermediate Similarity NPD6013 Approved
0.7925 Intermediate Similarity NPD6014 Approved
0.7925 Intermediate Similarity NPD6012 Approved
0.7925 Intermediate Similarity NPD6373 Approved
0.7917 Intermediate Similarity NPD5737 Approved
0.7917 Intermediate Similarity NPD6903 Approved
0.7917 Intermediate Similarity NPD6672 Approved
0.7917 Intermediate Similarity NPD7513 Clinical (unspecified phase)
0.7905 Intermediate Similarity NPD5701 Approved
0.79 Intermediate Similarity NPD4697 Phase 3
0.7885 Intermediate Similarity NPD5141 Approved
0.787 Intermediate Similarity NPD6882 Approved
0.787 Intermediate Similarity NPD8297 Approved
0.7843 Intermediate Similarity NPD5285 Approved
0.7843 Intermediate Similarity NPD5286 Approved
0.7843 Intermediate Similarity NPD4696 Approved
0.7822 Intermediate Similarity NPD4755 Approved
0.7789 Intermediate Similarity NPD1694 Approved
0.7789 Intermediate Similarity NPD7520 Clinical (unspecified phase)
0.7778 Intermediate Similarity NPD6401 Clinical (unspecified phase)
0.7767 Intermediate Similarity NPD5223 Approved
0.7708 Intermediate Similarity NPD5279 Phase 3
0.7708 Intermediate Similarity NPD3574 Clinical (unspecified phase)
0.77 Intermediate Similarity NPD7901 Clinical (unspecified phase)
0.77 Intermediate Similarity NPD7900 Approved
0.7692 Intermediate Similarity NPD5224 Approved
0.7692 Intermediate Similarity NPD4633 Approved
0.7692 Intermediate Similarity NPD5225 Approved
0.7692 Intermediate Similarity NPD5226 Approved
0.7677 Intermediate Similarity NPD5693 Phase 1
0.767 Intermediate Similarity NPD4700 Approved
0.7664 Intermediate Similarity NPD6686 Approved
0.7658 Intermediate Similarity NPD6868 Approved
0.7653 Intermediate Similarity NPD4753 Phase 2
0.7636 Intermediate Similarity NPD4632 Approved
0.7624 Intermediate Similarity NPD5695 Phase 3
0.7624 Intermediate Similarity NPD6356 Clinical (unspecified phase)
0.7619 Intermediate Similarity NPD5175 Approved
0.7619 Intermediate Similarity NPD5174 Approved
0.7609 Intermediate Similarity NPD5784 Clinical (unspecified phase)
0.7573 Intermediate Similarity NPD5696 Approved
0.7522 Intermediate Similarity NPD6335 Approved
0.75 Intermediate Similarity NPD3668 Phase 3
0.75 Intermediate Similarity NPD8035 Phase 2
0.75 Intermediate Similarity NPD8034 Phase 2
0.75 Intermediate Similarity NPD6274 Approved
0.7475 Intermediate Similarity NPD6080 Approved
0.7475 Intermediate Similarity NPD6673 Approved
0.7475 Intermediate Similarity NPD6904 Approved
0.7474 Intermediate Similarity NPD4221 Approved
0.7474 Intermediate Similarity NPD4223 Phase 3
0.7456 Intermediate Similarity NPD7101 Approved
0.7456 Intermediate Similarity NPD7100 Approved
0.7453 Intermediate Similarity NPD4754 Approved
0.7451 Intermediate Similarity NPD4629 Approved
0.7451 Intermediate Similarity NPD5210 Approved
0.7449 Intermediate Similarity NPD3573 Approved
0.7447 Intermediate Similarity NPD4695 Discontinued
0.7434 Intermediate Similarity NPD6009 Approved
0.7434 Intermediate Similarity NPD6317 Approved
0.7431 Intermediate Similarity NPD4061 Clinical (unspecified phase)
0.7423 Intermediate Similarity NPD5329 Approved
0.7423 Intermediate Similarity NPD5363 Approved
0.7368 Intermediate Similarity NPD6313 Approved
0.7368 Intermediate Similarity NPD6314 Approved
0.7347 Intermediate Similarity NPD4623 Approved
0.7347 Intermediate Similarity NPD4519 Discontinued
0.7339 Intermediate Similarity NPD4729 Approved
0.7339 Intermediate Similarity NPD5128 Approved
0.7339 Intermediate Similarity NPD4730 Approved
0.7339 Intermediate Similarity NPD5168 Approved
0.7327 Intermediate Similarity NPD5281 Approved
0.7327 Intermediate Similarity NPD5284 Approved
0.732 Intermediate Similarity NPD4197 Approved
0.7315 Intermediate Similarity NPD6008 Approved
0.7315 Intermediate Similarity NPD4768 Approved
0.7315 Intermediate Similarity NPD4767 Approved
0.73 Intermediate Similarity NPD6051 Approved
0.7263 Intermediate Similarity NPD7525 Registered
0.7248 Intermediate Similarity NPD6412 Phase 2
0.7241 Intermediate Similarity NPD6319 Approved
0.7234 Intermediate Similarity NPD3617 Approved
0.7227 Intermediate Similarity NPD7507 Approved
0.7216 Intermediate Similarity NPD5362 Discontinued
0.7216 Intermediate Similarity NPD4788 Approved
0.7207 Intermediate Similarity NPD5247 Approved
0.7207 Intermediate Similarity NPD5251 Approved
0.7207 Intermediate Similarity NPD5134 Clinical (unspecified phase)
0.7207 Intermediate Similarity NPD5249 Phase 3
0.7207 Intermediate Similarity NPD5135 Approved
0.7207 Intermediate Similarity NPD5169 Approved
0.7207 Intermediate Similarity NPD5955 Clinical (unspecified phase)
0.7207 Intermediate Similarity NPD4634 Approved
0.7207 Intermediate Similarity NPD5250 Approved
0.7207 Intermediate Similarity NPD5248 Approved
0.7204 Intermediate Similarity NPD6117 Approved
0.7203 Intermediate Similarity NPD7604 Phase 2
0.72 Intermediate Similarity NPD5208 Approved
0.7184 Intermediate Similarity NPD6001 Approved
0.7179 Intermediate Similarity NPD6291 Clinical (unspecified phase)
0.7179 Intermediate Similarity NPD5983 Phase 2
0.7179 Intermediate Similarity NPD6908 Approved
0.7179 Intermediate Similarity NPD6909 Approved
0.7172 Intermediate Similarity NPD4688 Approved
0.7172 Intermediate Similarity NPD4138 Approved
0.7172 Intermediate Similarity NPD5690 Phase 2
0.7172 Intermediate Similarity NPD6098 Approved
0.7172 Intermediate Similarity NPD4690 Approved
0.7172 Intermediate Similarity NPD5205 Approved
0.7172 Intermediate Similarity NPD4689 Approved
0.7172 Intermediate Similarity NPD4693 Phase 3
0.717 Intermediate Similarity NPD6404 Discontinued
0.7157 Intermediate Similarity NPD6050 Approved
0.7157 Intermediate Similarity NPD7637 Suspended
0.7157 Intermediate Similarity NPD6411 Approved
0.7143 Intermediate Similarity NPD5215 Approved
0.7143 Intermediate Similarity NPD5127 Approved
0.7143 Intermediate Similarity NPD7492 Approved
0.7143 Intermediate Similarity NPD5216 Approved
0.7143 Intermediate Similarity NPD5217 Approved
0.7129 Intermediate Similarity NPD7285 Clinical (unspecified phase)
0.7128 Intermediate Similarity NPD6116 Phase 1
0.7113 Intermediate Similarity NPD4269 Approved
0.7113 Intermediate Similarity NPD4270 Approved
0.7097 Intermediate Similarity NPD7339 Approved
0.7097 Intermediate Similarity NPD6942 Approved
0.7094 Intermediate Similarity NPD6054 Approved
0.7087 Intermediate Similarity NPD5779 Approved
0.7087 Intermediate Similarity NPD5778 Approved
0.7083 Intermediate Similarity NPD6616 Approved
0.7083 Intermediate Similarity NPD6336 Discontinued
0.708 Intermediate Similarity NPD6053 Discontinued
0.7059 Intermediate Similarity NPD5692 Phase 3
0.7053 Intermediate Similarity NPD6697 Approved
0.7053 Intermediate Similarity NPD6115 Approved
0.7053 Intermediate Similarity NPD6118 Approved
0.7053 Intermediate Similarity NPD6114 Approved
0.7049 Intermediate Similarity NPD7319 Approved
0.7033 Intermediate Similarity NPD4691 Approved
0.7025 Intermediate Similarity NPD7078 Approved
0.7021 Intermediate Similarity NPD3701 Clinical (unspecified phase)
0.7 Intermediate Similarity NPD5786 Approved
0.7 Intermediate Similarity NPD5280 Approved
0.7 Intermediate Similarity NPD4694 Approved
0.699 Remote Similarity NPD5694 Approved
0.6989 Remote Similarity NPD6113 Clinical (unspecified phase)
0.6979 Remote Similarity NPD7645 Phase 2

  Bioactivity similarity: Similar Natural Products in NPASS

Bioactivity similarity was calculated based on bioactivity descriptors of compounds. The bioactivity descriptors were calculated by a recently developed AI algorithm Chemical Checker (CC) [Nature Biotechnology, 38:1087–1096, 2020; Nature Communications, 12:3932, 2021], which evaluated bioactivity similarities at five levels:
A: chemistry similarity;
B: biological targets similarity;
C: networks similarity;
D: cell-based bioactivity similarity;
E: similarity based on clinical data.

Those 5 categories of CC bioactivity descriptors were calculated and then subjected to manifold projection using UMAP algorithm, to project all NPs on a 2-Dimensional space. The current NP was highlighted with a small circle in the 2-D map. Below figures: left-to-right, A-to-E.

A: chemistry similarity
B: biological targets similarity
C: networks similarity
D: cell-based bioactivity similarity
E: similarity based on clinical data